Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence

0
333

Funding Opportunity ID: 320416
Opportunity Number: RFA-PS-20-001
Opportunity Title: Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.941
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Additional Eligibility Categories:
Agency Code: HHS-CDC-HHSCDCERA
Agency Name: Department of Health and Human Services
Centers for Disease Control and Prevention – ERA
Posted Date: Feb 07, 2020
Close Date: Apr 14, 2020 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Last Updated Date: Feb 07, 2020
Award Ceiling: $1,800,000
Award Floor: $900,000
Estimated Total Program Funding: $3,600,000
Expected Number of Awards: 3
Description: The purpose of this Notice of Funding Opportunity (NOFO) is to develop and implement protocols and recruitment strategies to evaluate the performance (sensitivity and specificity) of HIV tests under development, and/or newly available HIV tests, for use in point-of-care settings in the United States using fresh (unprocessed) specimens such as whole blood and oral fluid.
Version: 1





Visit the Official Webpage For More Details on Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence

LEAVE A REPLY

Please enter your comment!
Please enter your name here